As of January 2025, Aprogen pharmaceuticals has a market cap of $300.38M. This makes Aprogen pharmaceuticals the world's 14244th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $84.45M | -36.21% |
2023 | $132.39M | -42.35% |
2022 | $229.62M | -44.42% |
2021 | $413.13M | -31.18% |
2020 | $600.30M | -2.95% |
2019 | $618.56M | -25.24% |
2018 | $827.36M | -41.83% |
2017 | $1.42B | 4.73% |
2016 | $1.36B | 22.15% |
2015 | $1.11B | 290.85% |
2014 | $284.46M | -10.87% |
2013 | $319.15M | -41.99% |
2012 | $550.19M | - |